1Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non -small -cell lung cancer to gefitinib[ J ]. N Engl J Med, 2005,352(8) :786 -792. 被引量：1
2Choong NW, Dietrich S, Seiwert TY, et al. Gefitinib response of erlotinib - refractory lung cancer involving meninges - role of EGFR mutation[J]. Nat Clin Pract Oncol, 2006,3( 1 ) : 50 -57. 被引量：1
3Gregory JR, Mark GK, Binsheng Z,et al. Prospective assessment of discontinuation and reinitiation of erllowed or gefitinib followed by the addition of everolimus [ J ]. Clinical Cancer Research, 2007,13(17) :5150 -5155. 被引量：1
